WeedMD Announces Mary’s Medicinals Topicals Product Release in Canada
Acclaimed Mary’s Transdermal Compound, produced exclusively in Canada by WeedMD, with expected availability to Starseed Medicinal’s patients starting late February, 2021
WeedMD Signs Exclusive Licensing Agreement with Mary’s Medicinals for Premium Line of Wellness Products
Award-winning products to be manufactured by CX Industries in Canada starting Q4 2020, for sale across all WeedMD’s medical and adult-use channels